Loading…

Metal complexes of bleomycin: evaluation of [Rh-105]-bleomycin for use in targeted radiotherapy

Bleomycin has been used as a carrier for several radioisotopes; however, its potential for clinical use has been limited either by the in vivo stability of the complexes or the half-life of the isotope used. The chemical, biological, and radiological properties of 105Rhodium appear to make it an ide...

Full description

Saved in:
Bibliographic Details
Published in:Nuclear medicine and biology 1999-05, Vol.26 (4), p.421-430
Main Authors: Brooks, R.C, Carnochan, P, Vollano, J.F, Powell, N.A, Zweit, J, Sosabowski, J.K, Martellucci, S, Darkes, M.C, Fricker, S.P, Murrer, B.A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bleomycin has been used as a carrier for several radioisotopes; however, its potential for clinical use has been limited either by the in vivo stability of the complexes or the half-life of the isotope used. The chemical, biological, and radiological properties of 105Rhodium appear to make it an ideal choice for targeted radiotherapy. The synthesis and purification of a hereto unreported 105Rhodium–bleomycin ( 105Rh-BLM) complex is described. The stability of this complex in plasma is sufficient to allow targeted delivery of the radioisotope. 57Cobalt–bleomycin was studied under identical conditions for comparative purposes. The suitability of 105Rh-BLM for targeted therapy, which appears to be limited by the renal clearance of this agent, is discussed.
ISSN:0969-8051
1872-9614
DOI:10.1016/S0969-8051(98)00109-7